| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 77131 |
1281816-04-3，Lys-Nε-MCC-DM1，ADC定制 |
79 |
wyh |
2024-12-19 |
| 77132 |
cas:120550-35-8，Biotin-PFP ester，五氟苯酚生物素酯 |
249 |
zyl |
2024-12-19 |
| 77133 |
MTS-ADO3A 三酸DOTA衍生物 |
121 |
h |
2024-12-19 |
| 77134 |
NHS-PEG2-NH-Xanomeline，ADC定制 |
97 |
wyh |
2024-12-19 |
| 77135 |
DOTA-DAsp-Tyr-Nle-Gly-Trp-Nle-Asp-Phe-NH2 DOTA-CCK |
141 |
h |
2024-12-19 |
| 77136 |
DOTA-MN2 2,2’-[4,10-双(2-{[2-(2-甲基-5-硝基-1H-咪唑-1-基)乙基]氨基}-2-氧乙基)-1,4,7,10-四氮杂环十二烷-1,7-二基]二乙酸 |
93 |
h |
2024-12-19 |
| 77137 |
cas:2123482-78-8，TETRAZINE-SS-BIOTIN 四嗪-双硫键-生物素 |
85 |
zyl |
2024-12-19 |
| 77138 |
GG-Tesirine，ADC定制 |
129 |
wyh |
2024-12-19 |
| 77139 |
DOTA-PEG-A20FMDV2 DOTA偶联聚乙二醇化的20个残基的线性肽 |
160 |
h |
2024-12-19 |
| 77140 |
MC-GGFG-Exatecan，ADC定制 |
161 |
wyh |
2024-12-19 |
| 77141 |
亲和素-AMF-DOTA(Nd) |
113 |
h |
2024-12-19 |
| 77142 |
DOTA偶联人血清白蛋白微球 DOTA-HSAM |
186 |
h |
2024-12-19 |
| 77143 |
MC-VA-PBD，MC-Val-Ala-PBD，ADC定制 |
216 |
wyh |
2024-12-19 |
| 77144 |
cas:2241685-22-1，DADPS Biotin Alykne |
108 |
zyl |
2024-12-19 |
| 77145 |
MC-vc-PAB-C6-Alpha-Amanitin，ADC定制 |
93 |
wyh |
2024-12-19 |
| 77146 |
MPB-MMAF，ADC定制 |
144 |
wyh |
2024-12-19 |
| 77147 |
DOTA–Bipy–RuII配位共轭物 |
182 |
h |
2024-12-19 |
| 77148 |
cas:1007215-91-9，1-(4-formylphenyl)-1-oxo-5,8,11-trioxa-2-azatridecan-13-oic acid |
135 |
zyl |
2024-12-19 |
| 77149 |
DOTA-cT84.66 DOTA偶联单克隆抗体cT84.66 |
99 |
h |
2024-12-19 |
| 77150 |
DOTA-Ahx-(D-Lys(6)-GnRH1)金属螯合剂DOTA偶联氨基己酸缀合D-赖氨酸 |
103 |
h |
2024-12-19 |
| 77151 |
DOTA-LRB 2-(6-(二乙基氨基)-3-(二乙基亚胺基)-3H-呫吨-9-基)-5-(N-(2-(2-(4,7,10-三(羧甲基)-1,4,7,10-四氮杂环十二烷-1-基)乙酰胺基 |
114 |
h |
2024-12-19 |
| 77152 |
DOTA-Y3-TATE DOTA偶联激动剂Y3-TATE |
108 |
h |
2024-12-19 |
| 77153 |
DOTA-2-脱氧-D-氨基葡萄糖 DOTA-DG |
150 |
h |
2024-12-19 |
| 77154 |
DOTA-c(RGDfK)DOTA偶联环肽 |
98 |
h |
2024-12-19 |
| 77155 |
SCN-DOTA-PCA DOTA-苯甲酰胺衍生物 |
125 |
h |
2024-12-19 |
| 77156 |
DOTA-N-羟基琥珀酰亚胺 DOTA-N-hydroxysuccinimide |
102 |
h |
2024-12-19 |
| 77157 |
低分子量CLT1肽靶向Gd(III)螯合物CLT1-dL-(Gd-DOTA) |
180 |
h |
2024-12-19 |
| 77158 |
DOTA-1,2-二硬脂酰-sn-甘油-3-磷酸乙醇胺脂质 |
166 |
h |
2024-12-19 |
| 77159 |
1,4,7-三氮杂环壬烷-1,4,7-三乙酸(NOTA17,19) |
114 |
h |
2024-12-19 |
| 77160 |
cas:1061569-06-9，4-formyl-N-(2-(2-hydroxyethoxy)ethyl)benzamide ADC抗体偶联药物 |
93 |
zyl |
2024-12-19 |
| 77161 |
DBCO-PEG4-VA-PBD，2241644-09-5，ADC定制 |
88 |
wyh |
2024-12-19 |
| 77162 |
Val-Cit-PAB-MMAE，cas:644981-35-1，ADC定制 |
100 |
wyh |
2024-12-19 |
| 77163 |
DOTA-GMSH 1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸(DOTA)偶联α-黑素细胞刺激素(α-MSH)类似物 |
117 |
h |
2024-12-19 |
| 77164 |
mDPR-Val-Cit-PAB-MMAE，1491152-26-1，ADC定制 |
97 |
wyh |
2024-12-19 |
| 77165 |
G3-(Gd-DTPA)(24)DOTA-钆(Gd)大分子造影剂 |
201 |
h |
2024-12-19 |
| 77166 |
DOTA-多柔比星 DOTA-DOX |
124 |
h |
2024-12-19 |
| 77167 |
聚(HPMA)-c(RGDyK)-DOTA |
80 |
h |
2024-12-19 |
| 77168 |
1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸(DOTA)螯合剂共轭的应变环辛烯衍生物二苄基环辛烯(DBCO) |
104 |
h |
2024-12-19 |
| 77169 |
PDDEC-NB；2-methyl-2-(pyridin-2-yldisulfanyl)propyl 4-nitrophenyl carbonate |
87 |
zyl |
2024-12-19 |
| 77170 |
(67)Ga-DOTA复合物共轭二膦酸盐(67)Ga-DOTA-Bn-SCN-HBP |
121 |
h |
2024-12-19 |
| 77171 |
MWCNT/PEI-FI-DOTA(Gd)-PEG 异硫氰酸荧光素(FI)和钆(Gd)螯合剂共价接枝聚乙烯亚胺修饰的多壁碳纳米管 |
129 |
h |
2024-12-19 |
| 77172 |
DOTA-Cys-hAb47 螯合剂DOTA偶联半胱氨酸-抗EphB4抗体hAb47和hAb131 |
172 |
h |
2024-12-19 |
| 77173 |
1,4,7,10-四氮杂环十二烷-N,N,N,N-四乙酸(DOTA)-F(ab)2-曲妥珠单抗 |
94 |
h |
2024-12-19 |
| 77174 |
DOTA-MG11(DOTA-DGlu-Ala-Tyr-Gly-Trp-Met-Asp)DOTA肽缀合物 |
126 |
h |
2024-12-19 |
| 77175 |
AcLys-PABC-VC-Aur0101， cas:1438851-17-2，ADC定制 |
151 |
wyh |
2024-12-19 |
齐岳微信公众号
官方微信
库存查询